Control of homeostasis by trace amine-associated receptors

通过微量胺相关受体控制体内平衡

基本信息

  • 批准号:
    RGPIN-2018-06201
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

My long-term goal is to determine the physiological roles of endogenous chemicals called trace amines and the proteins (trace amine-associated receptors; TAAR) that detect their presence. TAAR are present throughout the body in all vertebrate species, but with the exception of TAAR1 in the brain, little is known about their normal roles. Two of the most prominent sites of TAAR outside of the brain are the nasal passages and the pancreas. Unlike many other receptors, TAAR are not present at cell surfaces, rather residing inside the cell. This requires that trace amines cross cell membranes in order to bind to TAAR and participate in cell-cell communication. Our previous work has shown that this process is controlled by transporters that have not yet been identified. With respect to their role in the sense of smell, TAAR detect odours from diverse ecological sources including predators, spoiled food, and even putative pheromones. This detection causes innate behaviours (no learning is necessary) that are gender and species dependent, but the cellular basis of these effects are unknown. Our previous work showing trace amines readily cross cell membranes suggests effects may also occur due to trace amines crossing lung membranes following inhalation. Effects due to inhaled trace amines entering the bloodstream have not previously been considered. Our initial studies indicate that blood glucose levels are altered in response to inhalation of some, but not all, trace amines. We have also confirmed that in the pancreas TAAR control insulin release. How TAAR do this, however, is unknown. To progress toward our long-term goal, and address the knowledge gaps identified above, the studies in this proposal will:1) identify the transporters that control trace amine access to TAAR, 2) determine the role of TAAR in adaptive responses to environmental stressors of different ecological origins, and 3) determine the molecular mechanism of TAAR regulated insulin release. By filling these knowledge gaps new molecular targets for the regulation of trace amine function will be identified, which is crucial to elucidating the role of trace amine physiology in maintaining body functions. Identification of these targets will also be critical to future translational research by those investigating human disorders such as post-traumatic stress disorder, diabetes and obesity. Further, by determining the molecular basis of gender and species specific responses to chemicals associated with ecological hazards, some of which have life-or-death consequences, we will increase the understanding of adaptive stress responses in vertebrates, and the molecular basis of their physiological adaptations to habitat changes and ecological challenges.
我的长期目标是确定被称为微量胺的内源性化学物质和检测它们存在的蛋白质(微量胺相关受体; TAAR)的生理作用。TAAR存在于所有脊椎动物物种的全身,但除了大脑中的TAAR 1外,对其正常作用知之甚少。TAAR在脑外的两个最突出的部位是鼻道和胰腺。与许多其他受体不同,TAAR不存在于细胞表面,而是驻留在细胞内。这需要痕量胺穿过细胞膜以结合TAAR并参与细胞间通讯。我们以前的工作表明,这一过程是由尚未确定的转运蛋白控制的。关于它们在嗅觉中的作用,TAAR检测来自不同生态来源的气味,包括捕食者,变质的食物,甚至是推定的信息素。这种检测会导致依赖于性别和物种的先天行为(不需要学习),但这些影响的细胞基础尚不清楚。我们以前的工作表明,微量胺容易穿过细胞膜,这表明吸入后微量胺穿过肺膜也可能产生影响。由于吸入微量胺进入血液的影响以前没有被考虑过。我们的初步研究表明,血糖水平的改变,在响应吸入一些,但不是全部,微量胺。我们还证实了在胰腺中TAAR控制胰岛素的释放。然而,TAAR如何做到这一点尚不清楚。为了实现我们的长期目标,并解决上述知识差距,本提案中的研究将:1)确定控制微量胺进入TAAR的转运蛋白,2)确定TAAR在对不同生态来源的环境应激源的适应性反应中的作用,3)确定TAAR调节胰岛素释放的分子机制。通过填补这些知识空白,将确定用于调节微量胺功能的新分子靶点,这对于阐明微量胺生理学在维持身体功能中的作用至关重要。这些目标的确定也将是至关重要的未来翻译研究的那些调查人类疾病,如创伤后应激障碍,糖尿病和肥胖症。此外,通过确定性别和物种特异性反应的分子基础与生态危害,其中一些有生死后果的化学品,我们将增加脊椎动物的适应性应激反应的理解,以及他们的生理适应栖息地的变化和生态挑战的分子基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Berry, Mark其他文献

Restoring speech intelligibility for hearing aid users with deep learning.
  • DOI:
    10.1038/s41598-023-29871-8
  • 发表时间:
    2023-02-15
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Diehl, Peter Udo;Singer, Yosef;Zilly, Hannes;Schoenfeld, Uwe;Meyer-Rachner, Paul;Berry, Mark;Sprekeler, Henning;Sprengel, Elias;Pudszuhn, Annett;Hofmann, Veit M.
  • 通讯作者:
    Hofmann, Veit M.
Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis
  • DOI:
    10.1016/j.lungcan.2015.01.006
  • 发表时间:
    2015-04-01
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Kravchenko, Julia;Berry, Mark;Akushevich, Igor
  • 通讯作者:
    Akushevich, Igor
Fertility Intentions of HIV-1 Infected and Uninfected Women in Malawi: A Longitudinal Study
  • DOI:
    10.1007/s10461-009-9547-9
  • 发表时间:
    2009-06-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Taulo, Frank;Berry, Mark;Taha, Taha E.
  • 通讯作者:
    Taha, Taha E.
Same race and older partner selection may explain higher HIV prevalence among black men who have sex with men
  • DOI:
    10.1097/qad.0b013e3282f12f41
  • 发表时间:
    2007-11-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Berry, Mark;Raymond, H. Fisher;McFarland, Willi
  • 通讯作者:
    McFarland, Willi
Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer.
  • DOI:
    10.1001/jamanetworkopen.2022.33840
  • 发表时间:
    2022-09-01
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Titan, Ashley L.;Baiu, Ioana;Liou, Doug;Lui, Natalie S.;Berry, Mark;Shrager, Joseph;Backhus, Leah
  • 通讯作者:
    Backhus, Leah

Berry, Mark的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Berry, Mark', 18)}}的其他基金

Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2019
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2018
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
In vivo regulation of CNS neurotransmission by trace amines
微量胺对中枢神经系统神经传递的体内调节
  • 批准号:
    371703-2009
  • 财政年份:
    2013
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
In vivo regulation of CNS neurotransmission by trace amines
微量胺对中枢神经系统神经传递的体内调节
  • 批准号:
    371703-2009
  • 财政年份:
    2012
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
In vivo regulation of CNS neurotransmission by trace amines
微量胺对中枢神经系统神经传递的体内调节
  • 批准号:
    371703-2009
  • 财政年份:
    2011
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
In vivo regulation of CNS neurotransmission by trace amines
微量胺对中枢神经系统神经传递的体内调节
  • 批准号:
    371703-2009
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
In vivo regulation of CNS neurotransmission by trace amines
微量胺对中枢神经系统神经传递的体内调节
  • 批准号:
    371703-2009
  • 财政年份:
    2009
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
  • 批准号:
    82370796
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
  • 批准号:
    82370820
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
  • 批准号:
    82370879
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Cav1.2在束缚应激大鼠结肠平滑肌细胞钙稳态失衡中的作用机制
  • 批准号:
    30840045
  • 批准年份:
    2008
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目
食源性肥胖大鼠下丘脑摄食相关蛋白的筛选及功能研究
  • 批准号:
    30870791
  • 批准年份:
    2008
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
损伤和修复过程中皮层神经元钙稳态调控机制研究
  • 批准号:
    30670500
  • 批准年份:
    2006
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2019
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Control of homeostasis by trace amine-associated receptors
通过微量胺相关受体控制体内平衡
  • 批准号:
    RGPIN-2018-06201
  • 财政年份:
    2018
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Grants Program - Individual
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    10584565
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    9306110
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    10377928
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    9145231
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    10132341
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5
E3 泛素连接酶 FBXL5 对铁代谢的蛋白水解控制
  • 批准号:
    9030118
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了